一种1型糖尿病患者的生活
1Faculty of Arts, University of Regina.
概括
患有1型糖尿病的人每天都面临危险,生活必需品成本高昂. 连续血糖监测器 (CGM) 对于控制血糖和预防严重并发症至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 医疗技术 医疗技术 医学技术
- 公共卫生政策 公共卫生政策
背景情况:
- 1型糖尿病的管理包括对健康风险和并发症的持续警.
- 糖尿病供应的财务负担很大,包括胰岛素和持续血糖监测器 (CGM).
- 长期患有糖尿病的个人可能会经历低血糖意识受损,增加严重事件的风险.
研究的目的:
- 突出1型糖尿病患者每天面临的挑战和危险.
- 强调CGM等技术在预防危及生命的并发症方面的关键作用.
- 讨论糖尿病管理的财务影响和政府对供应的覆盖范围的影响.
主要方法:
- 一个1型糖尿病患者的个人叙述和实践经验.
- 描述糖尿病管理工具及其必要性.
- 分析低血糖意识受损的影响.
主要成果:
- 1型糖尿病患者的日常生活充满了从轻微疾病到长期并发症的潜在危险.
- 连续血糖监测器 (CGM) 对于检测和预防危险的低血糖事件至关重要,特别是对于那些意识受损的人来说.
- 加拿大政府计划支付糖尿病药物和用品,为患者提供经济救济,尽管并非所有费用都能支付.
结论:
- 有效管理1型糖尿病需要不断关注,先进的技术和大量的财务资源.
- 对于1型糖尿病患者,特别是那些低血糖意识受损的人来说,CGM是拯救生命的设备.
- 政府为糖尿病护理提供补贴的举措对于改善可访问性和降低患者的财务负担至关重要.
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
01:16Insulin: Dosing Regimen and Adverse Effects
163
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
163
01:15Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256